Home/Filings/4/0001209191-13-015852
4//SEC Filing

Shea Thomas 4

Accession 0001209191-13-015852

CIK 0001333170other

Filed

Mar 11, 8:00 PM ET

Accepted

Mar 12, 4:30 PM ET

Size

9.7 KB

Accession

0001209191-13-015852

Insider Transaction Report

Form 4
Period: 2013-03-09
Shea Thomas
SVP Manufacturing Operations
Transactions
  • Exercise/Conversion

    Common Stock

    2013-03-09+2,44530,848 total
  • Exercise/Conversion

    Restricted Stock Unit

    2013-03-092,4452,445 total
    Common Stock (2,445 underlying)
  • Tax Payment

    Common Stock

    2013-03-09$11.00/sh777$8,54730,071 total
Footnotes (4)
  • [F1]Shares of common stock acquired upon the vesting of restricted stock units in connection with the Company's 2011 Corporate Performance Share Plan.
  • [F2]This transaction reflects the withholding of shares of the Company's common stock to satisfy the reporting person's tax liability incurred in connection with the vesting of the second tranche of restricted stock units (the "Award"), granted on March 9, 2012 pursuant to the Company's 2011 Performance Share Plan.
  • [F3]Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
  • [F4]In March 2011, the Compensation Committee established the Company's 2011 Performance Share Plan with the amount of awards to be determined based upon the satisfaction of 2011 revenue, cash generation and net income targets. On March 9, 2012, the Compensation Committee granted the reporting person 7,334 restricted stock units, the Award, based on its evaluation of the achievement of performance criteria under the Company's 2011 Performance Share Plan. The Award vested 33 1/3rd% on the March 9, 2012, with the balance vesting in two equal installments on March 9, 2013 and March 9, 2014.

Issuer

NxStage Medical, Inc.

CIK 0001333170

Entity typeother

Related Parties

1
  • filerCIK 0001429894

Filing Metadata

Form type
4
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 4:30 PM ET
Size
9.7 KB